Clinical Trial: Study of Oglemilast for the Prevention of Asthma.
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Efficacy and Safety of Oglemilast in the Prevention of Exercise-Induced Bronchospasm
Brief Summary: The purpose of this study is to determine whether it is effective in the treatment of exercise-induced asthma and investigate the safety of oglemilast.
Detailed Summary:
Sponsor: Forest Laboratories
Current Primary Outcome: To determine the efficacy of oglemilast as compared to placebo in preventing exercise-induced asthma following 15 days of treatment.
Original Primary Outcome: Same as current
Current Secondary Outcome: To evaluate the safety of oglemilast over 2 weeks as determined by adverse events, physical examinations, vital signs, electrocardiograms, and laboratory examinations.
Original Secondary Outcome: Same as current
Information By: Forest Laboratories
Dates:
Date Received: May 4, 2006
Date Started: May 2006
Date Completion:
Last Updated: April 7, 2012
Last Verified: April 2012